港区芝|技術と知識と優しさの菅沼三田診療所|JR田町駅徒歩4分|都営線三田駅徒歩0分|内科|老年内科|外科|整形外科|皮膚科|泌尿器科

菅沼三田診療所トップバナートップバナー
文字サイズを変える
文字サイズ大文字サイズ中
菅沼三田診療所携帯サイトQRコード
携帯サイトはこちら
C.V.


論文

Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumura M, Fujii T, Yoshizawa T, Suzuki K, Akizuki M. Autoantibodies to calpastation (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
Proc. Natl. Acad. Sci. USA 1995 Aug 1; 92(16): 7267-71.

Egawa T, Kubota T, Otani Y, Kurihara N, Abe S, Kimata M, Tokuyama J, Wada N, Suganuma K, Kuwano Y, Kumai K, Sugino Y, Mukai M, Kitajima M. Surgically treated Cronkhite-Canada syndrome associated with gastric cancer.
Gastric Cancer. 2000 Dec 27;3(3):156-160.

Otani Y, Furukawa T, Suganuma K, Yoshida M, Saikawa Y, Kubota T, Kumai K, Mukai M, Kameyama K, Takami H, Kitajima M. Minimally invasive surgery for gastric carcinoid tumor.
Biomed Pharmacother. 2002;56 Suppl 1:217s-221s. Review

Suganuma K, Kubota T, Saikawa Y, Abe S, Otani Y, Furukawa T, Kumai K, Hasegawa H, Watanabe M, Kitajima M, Nakayama H, Okabe H. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.
Cancer Sci. 2003 Apr;94(4):355-9.

Sugiura T, Saikawa Y, Kubota T, Suganuma K, Otani Y, Watanabe M, Kumai K, Kitajima M. Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo.
In Vivo. 2003 May-Jun;17(3):229-33.

Suematsu M, Suganuma K, Kashiwagi S. Mechanistic probing of gaseous signal transduction in microcirculation.
Antioxid Redox Signal. 2003 Aug;5(4):485-92.

Suganuma K, Yoshihide Otani, Toshiharu Furukawa, Yoshiro Saikawa, Masashi Yoshida, Tetsuro Kubota, Koichiro Kumai, Kaori Kameyama, Makio Mukai, Masaki Kitajima Case of Gastric Carcinoid Tumors with Aggressive Lymphovascular Invasion and Lymph Node Metastasis
Gastric Cancer. 2003;6(4):255-61

Saikawa Y, Sugiura T, Toriumi F, Kubota T, Suganuma K, Isshiki S, Otani Y, Kumai K, Kitajima M Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.
Anticancer Res. 2004 Sep-Oct;24(5A):2723-8.

Akatsu T, Wakabayashi G, Aiura K, Suganuma K, Takigawa Y, Wada M, Kawachi S, Tanabe M, Ueda M, Shimazu M, Sakamoto M, Kitajima M. Intraductal growth of a nonfunctioning endocrine tumor of the pancreas.
J Gastroenterol. 2004 Jun;39(6):584-8. Review.

Hashiguchi N, Kubota T, Otani Y, Yoshida M, Maeda S, Tokuyama J, Wada N, Suganuma K, Kuwano Y, Kumai K, Sugino Y, Mukai M, Shin H, Kitajima M. Surgery for advanced gastric cancer after coronary artery bypass grafting using the right gastroepiploic artery: report of a case.
Surg Today. 2004;34(5):456-8.

Takahashi T, Yoshida M, Kubota T, Otani Y, Saikawa Y, Ishikawa H, Suganuma K, Akatsu Y, Kumai K, Kitajima M.
Morphologic analysis of gastroesophageal reflux diseases in patients after distal gastrectomy.
World J Surg. 2005 Jan;29(1):50-7.

Suganuma K, Tsukada K, Kashiba M, Tsuneshige A, Furukawa T, Kubota T, Goda N, Kitajima M, Yonetani T, Suematsu M. Erythrocytes with T-state-stabilized hemoglobin as a therapeutic tool for postischemic liver dysfunction.
Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1847-55.

Shinoda M, Tilles AW, Wakabayashi G, Takayanagi A, Harada H, Obara H, Suganuma K, Berthiaume F, Shimazu M, Shimizu N, Kitajima M, Tompkins RG, Toner M, Yarmush ML. reatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.
Tissue Eng. 2006 May;12(5):1313-23.

Shinoda M, Tilles AW, Kobayashi N, Wakabayashi G, Takayanagi A, Totsugawa T, Harada H, Obara H, Suganuma K, Berthiaume F, Shimazu M, Shimizu N, Tanaka N, Kitajima M, Tompkins RG, Toner M, Yarmush ML. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
J Surg Res. 2007 Jan;137(1):130-40. Epub 2006 Nov 1.

Suganuma K, Parekkadan B, Poll DV, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE. 2007 Sep 26;2(9):e941

Cho CH, Parashurama N, Park EYH, Suganuma K, Nahmias Y, Park J, Tilles AW, Berthiaume F, Yarmush ML. Homogenous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J. 2008 Mar;22(3):898-909. Epub 2007 Oct 17.

Yagi H., Parekkadan B., Suganuma, K. et. al. Mesenchymal Stem Cell and Hepatocyte provide a Synergistic Effect in Extracorporeal Treatment for Rat Acute Liver Failure, J. Hepatol., Tissue Eng Part A. 2009 Nov;15(11):3377-88.

Hosoe N, Imaeda H, Kashiwagi K, Suganuma K, et. al. Usefulness of endoscopic hemostasis using a short transparent hood and short hemoclips for non-variceal upper gastrointestinal bleeding, Dig Endosc. 2009 Apr;21(2):93-6.

Imaeda H, Hosoe N, Ida Y., Suganuma K, et. al. Novel technique of endoscopic submucosal dissection using an external grasping forceps for superficial gastric neoplasia, Dig Endosc. 2009 Apr;21(2):122-7.

Suda K, Takeuchi H, Hagiwara T, Miyasho T, Okamoto M, Kawasako K, Yamada S, Suganuma K, Wada N, Saikawa Y, Fukunaga K, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitagawa Y., Neutrophil elastase inhibitor improves survival of rats with clinically relevant sepsis., Shock. 2010 May;33(5):526-31.


国際特許

1.     Liposome stabilizing agengt  (2004-269442)
2.     Compositions, methods, and devices for treating liver disease (EP2076116) (as a member)


その他著書に標準外科学(分担)・ナースの外科学(分担)。雑誌などの寄稿多数